Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-263.31%
operating margin TTM
-337.8%
revenue TTM
73.29 Million
revenue per share TTM
2.45$
valuation ratios | |
|---|---|
| pe ratio | -0.07 |
| peg ratio | -0.00 |
| price to book ratio | 0.23 |
| price to sales ratio | 0.54 |
| enterprise value multiple | 1.20 |
| price fair value | 0.23 |
profitability ratios | |
|---|---|
| gross profit margin | 72.5% |
| operating profit margin | -337.8% |
| pretax profit margin | -117.52% |
| net profit margin | -263.31% |
| return on assets | -51.18% |
| return on equity | -122.55% |
| return on capital employed | -167.1% |
liquidity ratio | |
|---|---|
| current ratio | 0.85 |
| quick ratio | 0.74 |
| cash ratio | 0.31 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 463.85 |
| operating cycle | 640.67 |
| days of payables outstanding | 528.31 |
| cash conversion cycle | 112.36 |
| receivables turnover | 2.06 |
| payables turnover | 0.69 |
| inventory turnover | 0.79 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.35 |
| debt equity ratio | 2.33 |
| long term debt to capitalization | 0.61 |
| total debt to capitalization | 0.70 |
| interest coverage | -26.17 |
| cash flow to debt ratio | -0.80 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.59 |
| cash per share | 0.40 |
| operating cash flow per share | -0.59 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.80 |
| short term coverage ratios | -2.51 |
| capital expenditure coverage ratio | -304.58 |
Frequently Asked Questions
When was the last time Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) reported earnings?
Petros Pharmaceuticals, Inc. (PTPI) published its most recent earnings results on 13-11-2024.
What is Petros Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Petros Pharmaceuticals, Inc. (NASDAQ:PTPI)'s trailing twelve months ROE is -122.55%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Petros Pharmaceuticals, Inc. (PTPI) currently has a ROA of -51.18%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PTPI's net profit margin stand at?
PTPI reported a profit margin of -263.31% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PTPI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.85 in the most recent quarter. The quick ratio stood at 0.74, with a Debt/Eq ratio of 2.33.